Recordati Industria Chimica e Farmaceutica SPA (0KBS) Financial Statements
Recordati Industria Chimica e Farmaceutica SPA Financial Overview
Recordati Industria Chimica e Farmaceutica SPA's market cap is currently $10.94B. The company's EPS TTM is $2.43; its P/E ratio is 21.81; and it has a dividend yield of 2.53%. Recordati Industria Chimica e Farmaceutica SPA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.62B | $ 2.34B | $ 2.08B | $ 1.85B | $ 1.58B |
| Gross Profit | $ 1.79B | $ 1.60B | $ 1.42B | $ 1.29B | $ 1.15B |
| Operating Income | $ 719.74M | $ 638.90M | $ 558.01M | $ 437.33M | $ 490.19M |
| EBITDA | $ 887.00M | $ 795.37M | $ 708.16M | $ 559.35M | $ 578.35M |
| Net Income | $ 443.62M | $ 416.51M | $ 389.21M | $ 312.34M | $ 385.97M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 428.82M | $ 322.42M | $ 221.81M | $ 284.73M | $ 244.58M |
| Total Assets | $ 5.25B | $ 5.13B | $ 4.21B | $ 4.00B | $ 2.82B |
| Total Debt | $ 2.47B | $ 2.49B | $ 1.46B | $ 1.72B | $ 992.19M |
| Net Debt | $ 2.04B | $ -299.58M | $ 1.24B | $ 1.43B | $ 747.61M |
| Total Liabilities | $ 3.33B | $ 3.26B | $ 2.52B | $ 2.45B | $ 1.43B |
| Stockholders' Equity | $ 1.92B | $ 1.88B | $ 1.69B | $ 1.55B | $ 1.38B |
| Cash Flow | |||||
| Free Cash Flow | $ 511.77M | $ 535.10M | $ 102.06M | $ 365.35M | $ 404.29M |
| Operating Cash Flow | $ 596.90M | $ 569.92M | $ 485.32M | $ 461.69M | $ 491.65M |
| Investing Cash Flow | $ -80.84M | $ -844.94M | $ -379.62M | $ -767.12M | $ -87.50M |
| Financing Cash Flow | $ -407.02M | $ 372.11M | $ -168.91M | $ 341.28M | $ -355.94M |
Currency in EUR
